scispace - formally typeset
A

Arie Katz

Researcher at National Institutes of Health

Publications -  13
Citations -  7438

Arie Katz is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Glucose clamp technique & Insulin resistance. The author has an hindex of 11, co-authored 13 publications receiving 6790 citations.

Papers
More filters
Journal ArticleDOI

Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans.

TL;DR: It is concluded that QUICKI is an index of insulin sensitivity obtained from a fasting blood sample that may be useful for clinical research.
Journal ArticleDOI

Vitamin C as an Antioxidant: Evaluation of Its Role in Disease Prevention

TL;DR: Dose concentration studies of vitamin C in healthy people showed a sigmoidal relationship between oral dose and plasma and tissue vitamin C concentrations, so optimal dosing is critical to intervention studies using vitamin C.
Journal ArticleDOI

Vitamin C Pharmacokinetics: Implications for Oral and Intravenous Use

TL;DR: It is reported here that intravenous doses can produce plasma concentrations 30- to 70-fold higher than the maximum tolerated oral doses, and the role of vitamin C in cancer treatment should be reexamined, and insights from vitamin C pharmacokinetics can guide its clinical use.
Journal ArticleDOI

Repeatability characteristics of simple indices of insulin resistance: implications for research applications.

TL;DR: The test characteristics of the logarithmic transformation of the homeostasis model assessment and the Quantitative Insulin Sensitivity Check Index are superior to other simple indices of insulin sensitivity and helps explain their excellent correlations with formal measures both at baseline and with changes in insulin sensitivity.
Journal ArticleDOI

Insulin Stimulates Both Endothelin and Nitric Oxide Activity in the Human Forearm

TL;DR: Findings suggest that in the skeletal muscle circulation, insulin stimulates both ET-1 and NO activity, an imbalance between the release of these 2 substances may be involved in the pathophysiology of hypertension and atherosclerosis in insulin-resistant states associated with endothelial dysfunction.